The oral iron chelator deferasirox represses signaling through the mTOR in myeloid leukemia cells by enhancing expression of REDD1

スポンサーリンク

概要

• 論文の詳細を見る
• 2009-05-10

著者

• TAUCHI Tetsuzo

  First Department of Internal Medicine (Division of Hematology), Tokyo Medical University

• OHYASHIKI Kazuma

  First Department of Internal Medicine (Division of Hematology), Tokyo Medical University

• OKABE Seiichi

  First Department of Internal Medicine, Tokyo Medical University

• Ohyashiki K

  Tokyo Medical Univ. Tokyo Jpn

• Ohyashiki Kazuma

  First Department Of Internal Medicine (division Of Hematology) Tokyo Medical University

• Ohyashiki Kazuma

  First Department Of Internal Medicine (hematology Division) Tokyo Medical University

• OHYASHIKI Junko

  Intractable Immune System Diseases Research Center, Tokyo Medical University

• Ohyashiki Kazuma

  First Deparmtne Of Internal Medicine Tokyo Medical University

• Kobayashi Chiaki

  First Department Of Internal Medicine Tokyo Medical University

• Tsunoda Tatsuhiko

  Laboratory For Medical Informatics Snp Research Center Riken (institute Of Physical And Chemical Res

• Tauchi T

  First Department Of Internal Medicine (division Of Hematology) Tokyo Medical University

• HAMAMURA Ryoko

  First Department of Internal Medicine, Tokyo Medical University

• Okabe Seiichi

  First Department Of Internal Medicine Tokyo Medical University

• Ohyashiki Junko

  Intractable Diseases Therapeutic Research Center Tokyo Medical University

• Tauchi Tetsuzo

  First Department Of Internal Medicine (division Of Hematology) Tokyo Medical University

• Tauchi Tetsuzo

  Department Of Medicine (hematology/oncology) Indiana University School Of Medicine Walther Oncology

• Hamamura Ryoko

  First Department Of Internal Medicine Tokyo Medical University

関連論文

• OE-294 A Functional Variation in a Gene Encoding One of Galectin-2 Binding Proteins Confers Risk of Myocardial Infarction in Asian Populations(OE50,Coronary Circulation/Chronic Coronary Disease (Basic/Clinical) (IHD),Oral Presentation (English),The 73rd A
• OE-009 Identification of a Locus on Chromosome 5p that Confers Risk of Coronary Artery Disease by Genome Wide Association Study(OE02,ACS/AMI (Basic) (IHD),Oral Presentation (English),The 73rd Annual Scientific Meeting of The Japanese Circulation Society)
• FRS-004 Large Scale SNPs Association Study to Identify Genes Confer Risk of Myocardial Infarction(FRS1,New Molecules for Cardiovascular Regulation (M),Featured Research Session (English),The 73rd Annual Scientific Meeting of The Japanese Circulation Socie
• Successful prior treatment with dasatinib followed by stem cell transplantation in a patient with CML in blastic crisis with a BCR-ABL mutation
• Endobronchial Minute Leiomyoma in a Patient with Malignant Lymphoma
• Enhanced expression of the EVI1 gene in NUP98/HOXA-expressing leukemia cells
• A functional SNP in the NKX2.5-binding site of ITPR3 promoter is associated with susceptibility to systemic lupus erythematosus in Japanese population
• A functional SNP in ITIH3 is associated with susceptibility to myocardial infarction
• The characteristics of relapse in adult-onset minimal-change nephrotic syndrome
• PJ-152 A functional SNP in the Proteasome Subunit Alpha Type 6 Gene confers Risk of Myocardial Infarction in Japanese Population(Acute myocardial infarction, basic-2, The 71st Annual Scientific Meeting of the Japanese Circulation Society)
• OJ-212 Identification of a Novel non-coding RNA, MIAT, that Confers Risk of Myocardial Infarction(Genetics/Genetically engineered models/Gene therapy-2(H/M), The 71st Annual Scientific Meeting of the Japanese Circulation Society)
• A case of Mikulicz's disease complicated with severe interstitial nephritis associated with IgG4
• Arterial Stiffness in Patients with Non-Diabetic Chronic Kidney Disease (CKD)
• Low-Dose Losartan Therapy Reduces Proteinuria in Normotensive Patients with Immunoglobulin A Nephropathy
• Clinical assessment of low-dose steroid therapy for patients with IgA nephropathy : a prospective study in a single center
• PJ-224 Primal role of intracellular zinc in PKC-dependent monocyte signalling and adhesive interaction(Atherosclerosis, basic(06)(IHD),Poster Session(Japanese),The 72nd Annual Scientific Meeting of the Japanese Circulation Society)
• Prediction of Sensitivity to STI571 among Chronic Myeloid Leukemia Patients by Genome-wide cDNA Microarray Analysis
• Multicenter Prospective Study of Clonal Complications in Adult Aplastic Anemia Patients following Recombinant Human Granulocyte Colony-Stimulating Factor (Lenograstim) Administration
• Efficacy and Safety of Imatinib Mesylate for Patients in the First Chronic Phase of Chronic Myeloid Leukemia : Results of a Japanese Phase II Clinical Study
• Activity of a novel Aurora kinase inhibitor against the T315I mutant form of BCR-ABL : In vitro and in vivo studies
• Sustained Complete Cytogenetic Remission in a Patient with Chronic Myeloid Leukemia after Discontinuation of Imatinib Mesylate Therapy
• Japanese epidemiological survey with consensus statement on Japanese guidelines for treatment of iron overload in bone marrow failure syndromes
• Restoration of cardiac function by an iron chelator, deferasirox, in a patient with aplastic anemia and cardiac iron overload
• Disparity Between the Macroglobulin-Producing Components of 2 Cases of Follicular Lymphoma With Waldenstrom's Macroglobulinemia
• Homeobox genes in hematopoiesis and leukemogenesis
• Myeloid/Natural Killer Cell Precursor Acute Leukemia Accompanied by Homozygous Protein C Deficiency
• Can Eradication Therapy for Helicobacter pylori Really Inprove the Thrombocytopenia in Idiopathic Thrombocytopenic Purpura? Our Experience and a Literature Review
• Thrombocytopenia Induced by Imatinib Mesylate(Glivec) in Patients with Chronic Myelogenous Leukemia : Is 400 mg Daily of Imatinib Mesylate an Optimal Starting Dose for Japanese Patients?
• IgA-λ/IgG-к Biclonal Myeloma in which Two Clones Proliferated in Individual Sites
• A safety, pharmacokinetic and pharmacodynamic investigation of deferasirox (Exjade^【○!R】, ICL670) in patients with transfusion-dependent anemias and iron-overload : a Phase I study in Japan
• Radioimmunotherapy of human synovial sarcoma using a monoclonal antibody against FZD10
• Current and future perspectives on the TARGET system : the registration system for Glivec^【○!R】 established by the JSH
• Leukocytosis is linked to thrombosis at diagnosis, while JAK2 V617F mutation is associated with thrombosis during the course of essential thrombocythemia
• The Prophylactic Effect of Itraconazole Capsules and Fluconazole Capsules for Systemic Fungal Infections in Patients with Acute Myeloid Leukemia and Myelodysplastic Syndromes : A Japanese Multicenter Randomized, Controlled Study
• Cloning, expression analysis, and chromosomal localization of a novel butyrophilin-like receptor
• Isolation and chromosomal mapping of a novel human gene showing homology to Na^+/PO4 cotransporter
• Expression profiles of two types of human knee-joint cartilage
• The oral iron chelator deferasirox represses signaling through the mTOR in myeloid leukemia cells by enhancing expression of REDD1
• Relapse of chronic myeloid leukemia-chronic phase 14 years after allogeneic hematopoietic stem cell transplantation
• BCR/ABL signal transduction
• Non-radioisotopic and Semi-quantitative Procedure for Terminal Repeat Amplification Protocol
• Trisomy 11 Acute Myeloid Leukemia: 5 Additional Cases From the Japan Adult Leukemia Study Group AML-92 and AML-95 Databases
• Activation of an estrogen/estrogen receptor signaling by BIG3 through its inhibitory effect on nuclear transport of PHB2/REA in breast cancer
• Severe Starvation Hypoglycemia and Congestive Heart Failure Induced by Thyroid Crisis, with Accidentally Induced Severe Liver Dysfunction and Disseminated Intravascular Coagulation
• Hypereosinophilia in a Patient with Invasive Thymoma with Clonal T-Lymphocyte Expansion Expressing CD4, CD8, and CD25 Antigens
• Bone Marrow Cytogenetic Complete Remission Achieved by Interferon-α Plus Cytarabine Ocfosfate Therapy in a Patient With Chronic Myelogenous Leukemia During Extramedullary Blast Crisis
• Myelodysplastic Syndrome Accompanied by Addison's Disease and Multiple Autoimmune Phenomena: Steroid Therapy Resolved Cytopenias and All Immune Disorders
• Imatinib Mesylate in Combination with Other Chemotherapeutic Agents for Chronic Myelogenous Leukemia
• Brain Abscess in Acute Myeloid Leukemia
• Estimation of cardiac left ventricular ejection fraction in transfusional cardiac iron overload by R2^* magnetic resonance
• A Long-Survival Case of Systemic AL Amyloidosis with Nephrotic Syndrome
• Clinical efficacy and safety of biapenem for febrile neutropenia in patients with underlying hematopoietic diseases : a multi-institutional study
• An Adult Case of Acute Disseminated Encephalomyelitis Accompanied with Measles Infection
• The Second Generation of BCR-ABL Tyrosine Kinase Inhibitors
• 5q-syndrome in Japan
• Phase I and II study of azacitidine in Japanese patients with myelodysplastic syndromes
• SNPs on chromosome 5p15.3 associated with myocardial infarction in Japanese population
• Induction of remission following a single dose of rituximab alone in a patient with minimal change nephrotic syndrome
• Long-term beneficial effects of angiotensin-converting enzyme inhibitor and angiotensin receptor blocker therapy for patients with advanced immunoglobulin A nephropathy and impaired renal function
• A case of acute renal failure after exercise with renal hypouricemia demonstrated compound heterozygous mutations of uric acid transporter 1
• Comparison of inhibitors of renin-angiotensin-aldosterone system (RAS) and combination therapy of steroids plus RAS inhibitors for patients with advanced immunoglobulin A nephropathy and impaired renal function

もっと見る 閉じる

スポンサーリンク